Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 19Unknown 6Active not recruiting 6Withdrawn 4Terminated 4Recruiting 3Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Dietary Supplements × Clear all
NCT07599501 2026-05-20

NUTRICOLOR

Istituto Clinico Humanitas

Phase NA Not yet recruiting
190 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07067359 2025-07-16

INSECNT

Sichuan University

Phase NA Not yet recruiting
200 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT07064668 2025-07-15

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

Tongji Hospital

Phase 2 Not yet recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡